Mitochondrial Disease clinical trials

Explore recruiting mitochondrial disease clinical trials.

Recruiting mitochondrial disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mitochondrial Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Folinic acid therapy in patients with Kearns-Sayre syndrome (KSS) and cerebral folate deficiency - mitoFolat

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase IIa non-randomized open single-arm study, multicentre clinical trial to determine the efficacy and safety of coenzyme Q (Ubiquinol) for patients with mitochondrial disorders and cerebellar ataxias

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a Safety, Tolerability, and Pharmacodynamic Study of OMT-28 in PMD patients with myopathy and/or cardiomyopathy and inflammation (PMD-OPTION)

Germany, Italy, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, single-arm extension study to evaluate the long-term safety, tolerability, and efficacy of KL1333 (napazimone) in patients with primary mitochondrial disease

Belgium, Germany, Czechia, Spain, Denmark, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, randomised, double-blind, placebo-controlled, parallel-group, pivotal trial to assess the efficacy and safety of sonlicromanol in adult subjects with a genetically confirmed mitochondrial DNA tRNALeu(UUR) m.3243A>G variant.

Italy, Germany, France, Netherlands, Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mitochondrial Disease trials by city

Mitochondrial Disease in Toronto Mitochondrial Disease in Vancouver Mitochondrial Disease in Montreal Mitochondrial Disease in Calgary Mitochondrial Disease in Edmonton Mitochondrial Disease in Ottawa Mitochondrial Disease in Winnipeg Mitochondrial Disease in Quebec City Mitochondrial Disease in Hamilton Mitochondrial Disease in Kitchener Mitochondrial Disease in London Mitochondrial Disease in Halifax Mitochondrial Disease in New York Mitochondrial Disease in Los Angeles Mitochondrial Disease in Chicago Mitochondrial Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease